Deep 6 AI announced the addition of Trial Recommender to its artificial intelligence (AI)-driven clinical trial acceleration platform. Trial Recommender lets physicians and their patients easily discover and participate in clinical research.
Leveraging the Deep 6 AI and NLP platform, Trial Recommender offers precision-matched clinical trial opportunities for patients, during their visit with a treating physician, based on real-time structured and unstructured clinical data.
Starting inside their EMR or the Trial Recommender portal, a physician can review precision-matched trial opportunities for their patients to determine study fit and impact. This empowers doctors to give their patients access to treatments and make data-driven decisions about their care. Trial Recommender also operates across the Deep 6 site network.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.